| P50 | author | Maria Pina Dore | Q85756625 |
| | Giovanni Mario Pes | Q39188349 |
| | Stefano Bibbò | Q40631913 |
| P2093 | author name string | Giuseppe Delitala | |
| | Alessandro P Delitala | |
| P2860 | cites work | Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. | Q54468190 |
| | Genetics of type 1 diabetes | Q56899103 |
| | Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice | Q58061330 |
| | UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes | Q58678933 |
| | Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome | Q21132451 |
| | Diversity of the human intestinal microbial flora | Q24544241 |
| | Toward defining the autoimmune microbiome for type 1 diabetes | Q24629032 |
| | Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes | Q24632382 |
| | Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 |
| | Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection | Q24678832 |
| | Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution | Q26777399 |
| | Diversity, stability and resilience of the human gut microbiota | Q28274959 |
| | Gut Microbiota in Health and Disease | Q29616812 |
| | Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. | Q33410248 |
| | Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats | Q33576806 |
| | Gut microbiota, probiotics and diabetes. | Q33831849 |
| | Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats | Q33864397 |
| | Focused specificity of intestinal TH17 cells towards commensal bacterial antigens | Q34026652 |
| | Role of the gut microbiota in immunity and inflammatory disease | Q34036490 |
| | Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes | Q34063601 |
| | Early Infant Feeding and Risk of Developing Type 1 Diabetes–Associated Autoantibodies | Q34266396 |
| | Compositional and functional features of the gastrointestinal microbiome and their effects on human health | Q34274976 |
| | Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat | Q34283907 |
| | Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention | Q34319528 |
| | Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies | Q34353547 |
| | Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial | Q34477816 |
| | Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora | Q34503563 |
| | Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. | Q34518641 |
| | Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity | Q34542290 |
| | Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity | Q34567034 |
| | Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study | Q34596660 |
| | Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes | Q34668698 |
| | Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study | Q35043312 |
| | Metabolism in 2013: The gut microbiota manages host metabolism | Q35063354 |
| | Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency | Q37356031 |
| | Beta cell apoptosis in diabetes | Q37424013 |
| | Fecal microbiota imbalance in Mexican children with type 1 diabetes | Q37501593 |
| | Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. | Q37664261 |
| | Regulation of the immune system by the resident intestinal bacteria. | Q37716899 |
| | Etiology of type 1 diabetes | Q37735981 |
| | From the gut to the peripheral tissues: the multiple effects of butyrate. | Q37799401 |
| | Viral infections and molecular mimicry in type 1 diabetes | Q38050863 |
| | Fecal microbiota transplantation: techniques, applications, and issues | Q38055822 |
| | The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland | Q38057812 |
| | Vaccine against autoimmune disease: can helminths or their products provide a therapy? | Q38086987 |
| | Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes | Q38447310 |
| | Type 1 diabetes associated autoimmunity | Q38745722 |
| | Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents | Q39433904 |
| | Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse | Q40409987 |
| | The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography | Q40412268 |
| | Viruses and other perinatal exposures as initiating events for beta-cell destruction | Q41695561 |
| | Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in NOD mice | Q43949037 |
| | Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele | Q44270655 |
| | Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. | Q44769295 |
| | Early infant feeding and type 1 diabetes | Q44850840 |
| | Prevention of virus-induced type 1 diabetes with antibiotic therapy | Q45354723 |
| | Compromised gut microbiota networks in children with anti-islet cell autoimmunity | Q46922105 |
| | Significance of cow's milk protein antibodies as risk factor for childhood IDDM: interactions with dietary cow's milk intake and HLA-DQB1 genotype. Childhood Diabetes in Finland Study Group. | Q50903257 |
| | Differences in the gut microbiota of healthy children and those with type 1 diabetes. | Q51164852 |
| | Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. | Q51369994 |
| | A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. | Q52950394 |
| | Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. | Q53080524 |
| | A missing link in the hygiene hypothesis? | Q53873028 |
| | Allelic variant in CTLA4 is associated with thyroid failure and faster β-cell exhaustion in latent autoimmune diabetes in adults. | Q54173599 |
| | Role of the microbiome in energy regulation and metabolism | Q35100445 |
| | Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. | Q35105043 |
| | Role of viruses and other microbes in the pathogenesis of type 1 diabetes | Q35115373 |
| | The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity | Q35142299 |
| | Long term effect of gut microbiota transfer on diabetes development | Q35157830 |
| | Therapeutic modulation of gut microbiota: current clinical applications and future perspectives | Q35183703 |
| | Microbiota: host interactions in mucosal homeostasis and systemic autoimmunity | Q35184383 |
| | Aberrant gut microbiota composition at the onset of type 1 diabetes in young children | Q35188386 |
| | Fermentable fibres condition colon microbiota and promote diabetogenesis in NOD mice. | Q35207919 |
| | The cross talk between microbiota and the immune system: metabolites take center stage | Q35213604 |
| | Does the microbiota play a role in the pathogenesis of autoimmune diseases? | Q35443254 |
| | Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes | Q35483922 |
| | The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy | Q35538584 |
| | Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice. | Q35554609 |
| | The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes | Q35557877 |
| | Phenotypic heterogeneity of latent autoimmune diabetes in adults identified by body composition analysis. | Q35584141 |
| | Enteropathy precedes type 1 diabetes in the BB rat. | Q35596913 |
| | The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA | Q35627540 |
| | The gut microbiota and Type 1 Diabetes. | Q35655645 |
| | Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. | Q35659179 |
| | Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes | Q35661927 |
| | Microorganisms and autoimmunity: making the barren field fertile? | Q35701697 |
| | Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population | Q35820963 |
| | The role of the intestinal microbiota in type 1 diabetes mellitus | Q35884681 |
| | Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment | Q35896724 |
| | Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice | Q35913697 |
| | Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans | Q36004640 |
| | The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept? | Q36263439 |
| | Milk Proteins in the Etiology of Insulin-Dependent Diabetes Mellitus (IDDM) | Q36689792 |
| | Fecal microbiota composition differs between children with β-cell autoimmunity and those without | Q36720600 |
| | Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model | Q36792480 |
| | Interactions and competition within the microbial community of the human colon: links between diet and health. | Q36808079 |
| | Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide | Q36867412 |
| | The normal intestinal microbiota. | Q36925502 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 11-22 | |
| P577 | publication date | 2016-11-29 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | Is there a role for gut microbiota in type 1 diabetes pathogenesis? | |
| P478 | volume | 49 | |